Myocardial Injury and Prognosis in Hospitalized COVID-19 Patients in Brazil: Results From The Brazilian COVID-19

Hannah Cardoso Barbosa1, Maria Auxiliadora Parreiras Martins1, Jordana Cristina de Jesus2

  • 1Hospital das Clínicas - Universidade Federal de Minas Gerais,Belo Horizonte, MG - Brasil.

Insights

Myocardial injury in COVID-19 patients independently predicted higher in-hospital mortality and the need for mechanical ventilation. This finding highlights the importance of cardiac biomarkers in assessing COVID-19 severity.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Cardiovascular complications are key to COVID-19 pathogenesis and prognosis.
  • Limited data exists on the prognostic value of troponin and myocardial injury in Latin American COVID-19 patients.

Purpose of the Study:

  • To determine if myocardial injury independently predicts in-hospital mortality.
  • To assess if myocardial injury predicts the need for invasive mechanical ventilation support in hospitalized COVID-19 patients.

Main Methods:

  • A cohort study involving 2,925 hospitalized COVID-19 patients from the Brazilian COVID-19 Registry (March-September 2020).
  • Primary outcomes were in-hospital mortality and invasive mechanical ventilation.
  • Poisson regression with robust variance was used to estimate outcome models.

Main Results:

  • 27.3% of patients had myocardial injury, with higher comorbidity rates.
  • Patients with myocardial injury showed elevated levels of cardiac biomarkers and inflammatory markers.
  • High troponin levels were associated with a significantly increased risk of death (RR 2.03) and mechanical ventilation (RR 1.87).

Conclusions:

  • Cardiac injury is an independent predictor of in-hospital mortality in COVID-19 patients.
  • Myocardial injury also independently predicts the need for invasive mechanical ventilation support.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
16
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46